Human Molecular GeneticsGeneticsPeer-reviewed journal article
Determining off-target effects of splice-switching antisense oligonucleotides using short read RNAseq in neuronally differentiated human induced pluripotent stem cells
Elsa C. KuijperiD, Linda van der Graaf, Barry A. PepersiD, Mariana Guimarães RamosiD, Sylvia KorhorniD, Lodewijk J.A. TooneniD, Davy CatsiD, Ronald A.M. BuijseniD, Eleni MinaiD, Hailiang MeiiD, Willeke van Roon‐MomiD
Abstract
Antisense oligonucleotides (AONs) are small pieces of chemically modified DNA or RNA that bind to RNA in a sequence-specific manner based on Watson-Crick base-pairing. Splice-switching AONs are designed to modulate pre-mRNA splicing, thereby for instance restoring protein expression or modifying the eventual protein to restore its function or reduce its toxicity. Given the current lack of in silico methods that adequately predict off-target splicing events, assessment of off-target effects of AONs in human cells using RNAseq could be a promising approach. The identification and prioritization of potential off-target effects for validation and further investigation into the biological relevance would contribute to the development of safe and effective AONs. In this study, we used three different splice-switching AONs targeting three different human transcripts to study their transcriptome-wide, hybridization-dependent off-target effects with short read RNAseq. Using the computational tools rMATS and Whippet, we identified differential splicing events of which only a minority could be explained by hybridization, illustrating the difficulty of predicting off-target effects based on sequence homology. The main splicing events could all be validated with RT-PCR. Furthermore, from the three AONs studied, one AON induced considerably more changes in gene expression and splicing compared to the two other AONs assessed, which was confirmed in a validation experiment. Our study demonstrates that the interpretation of short read RNAseq data to determine off-target effects is challenging. Nonetheless, we showed that valuable results can be obtained as it allows the comparison of toxicity between different AONs within an experiment and identification of AON-specific off-target profiles.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: statistical model
- Citations
- 5
- FWCI
- 1.49
- Field percentile
- top 18%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptome-Wide Off-Target Effects of Steric-Blocking Oligonucleotides
Erle M. Holgersen, Shreshth Gandhi, … Amit G. Deshwar·Nucleic Acid TherapeuticsPeer-reviewed·Aug 13, 2021
- OpenASO: RNA Rescue--designing splice-modulating antisense oligonucleotides through community science
Victor Tse, Martin Guiterrez, … Michael D. Stone·RNAPeer-reviewed·May 27, 2025
- ASOFormer: a Transformer-based model for predicting antisense oligonucleotide efficacy to support therapeutic candidate prioritization
Nicholas C. Dove, Yuhao Min, … Xue Wang·bioRxiv·Sep 24, 2026
- Antisense oligonucleotides targeting transcription termination windows disrupt mRNA 3' end processing and decrease gene expression
Kinga Winczura, Lars Joenson, … Lukasz Jan Kielpinski·Nature CommunicationsPeer-reviewed·Oct 9, 2026
- Development and validation of an AI/ML platform for the discovery of splice-switching oligonucleotide targets
Alyssa D Fronk, Miguel Ángel Manzanares, … Martin Akerman·bioRxiv·Oct 14, 2022
- Targeted blocking of gene splicing can dysregulate intron-embedded microRNAs
Md Hasan Ali, Wojciech Kwiatkowski, … Savani Anbalagan·bioRxiv·Dec 4, 2024